Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.

Jiang L, Lin C, Song L, Wu J, Chen B, Ying Z, Fang L, Yan X, He M, Li J, Li M.

J Clin Invest. 2012 Jan;122(1):33-47. doi: 10.1172/JCI58849. Epub 2011 Dec 12.

2.

NF-kappaB and STAT3 signaling in glioma: targets for future therapies.

Atkinson GP, Nozell SE, Benveniste ET.

Expert Rev Neurother. 2010 Apr;10(4):575-86. doi: 10.1586/ern.10.21. Review.

3.

Malignant glioma: lessons from genomics, mouse models, and stem cells.

Chen J, McKay RM, Parada LF.

Cell. 2012 Mar 30;149(1):36-47. doi: 10.1016/j.cell.2012.03.009. Review.

4.

Adhesion molecules and the extracellular matrix as drug targets for glioma.

Shimizu T, Kurozumi K, Ishida J, Ichikawa T, Date I.

Brain Tumor Pathol. 2016 Apr;33(2):97-106. doi: 10.1007/s10014-016-0261-9. Epub 2016 Mar 18. Review.

PMID:
26992378
5.

Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment.

Vlahopoulos SA, Cen O, Hengen N, Agan J, Moschovi M, Critselis E, Adamaki M, Bacopoulou F, Copland JA, Boldogh I, Karin M, Chrousos GP.

Cytokine Growth Factor Rev. 2015 Aug;26(4):389-403. doi: 10.1016/j.cytogfr.2015.06.001. Epub 2015 Jun 20. Review.

6.

MicroRNAs in cancer: small molecules with a huge impact.

Iorio MV, Croce CM.

J Clin Oncol. 2009 Dec 1;27(34):5848-56. doi: 10.1200/JCO.2009.24.0317. Epub 2009 Nov 2. Review.

7.
8.

The role of NF-κB in the pathogenesis of glioma.

Puliyappadamba VT, Hatanpaa KJ, Chakraborty S, Habib AA.

Mol Cell Oncol. 2014 Dec 23;1(3):e963478. doi: 10.4161/23723548.2014.963478. eCollection 2014 Dec 23. Review.

Supplemental Content

Support Center